In agreement with previous studies [33,34], our iPSC-derived sensory neurons from FRDA patients accurately reflected the disease phenotype, exhibiting increased levels of mROS, reduced mitochondrial copy number, and decreased mRNA and protein levels of frataxin and NRF2 compared to sensory neurons derived from healthy individuals. This evidence concerns the gene NFE2L2 and Friedreich ataxia.